Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 50049289
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238227(CHEMBL4071377)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM8961(CHEMBL95 | Cognex | cid_1935 | CHEMBL1337960 | 1,2...)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238223(CHEMBL4102333)
Affinity DataIC50: 3.30nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238216(CHEMBL4095535)
Affinity DataIC50: 5.80nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238235(CHEMBL4081915)
Affinity DataIC50: 8.80nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238224(CHEMBL4094081)
Affinity DataIC50: 14nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238225(CHEMBL4060011)
Affinity DataIC50: 18nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238213(CHEMBL4066548)
Affinity DataIC50: 18nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238212(CHEMBL4077952)
Affinity DataIC50: 20nMAssay Description:Inhibition of AChE (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238236(CHEMBL4068149)
Affinity DataIC50: 26nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238220(CHEMBL4074062)
Affinity DataIC50: 28nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238222(CHEMBL4094591)
Affinity DataIC50: 30nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50117592(1-Benzyl-4-(5,6-dimethoxy-1-oxo-indan-2-ylmethyl)-...)
Affinity DataIC50: 37nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238228(CHEMBL4092048)
Affinity DataIC50: 41nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238240(CHEMBL4084371)
Affinity DataIC50: 60nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238219(CHEMBL4072999)
Affinity DataIC50: 91nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238220(CHEMBL4074062)
Affinity DataIC50: 262nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238239(CHEMBL4099873)
Affinity DataIC50: 262nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238229(CHEMBL4061527)
Affinity DataIC50: 428nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238231(CHEMBL4105085)
Affinity DataIC50: 653nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238215(CHEMBL4076930)
Affinity DataIC50: 678nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238218(CHEMBL4064413)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238238(CHEMBL4093567)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238237(CHEMBL4099794)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238217(CHEMBL4092123)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238234(CHEMBL4101303)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238233(CHEMBL4072865)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238232(CHEMBL4083445)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238230(CHEMBL4081776)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238240(CHEMBL4084371)
Affinity DataIC50: 1.62E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238216(CHEMBL4095535)
Affinity DataIC50: 1.79E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238213(CHEMBL4066548)
Affinity DataIC50: 1.92E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238222(CHEMBL4094591)
Affinity DataIC50: 2.99E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238236(CHEMBL4068149)
Affinity DataIC50: 3.06E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238223(CHEMBL4102333)
Affinity DataIC50: 3.34E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238239(CHEMBL4099873)
Affinity DataIC50: 3.63E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238219(CHEMBL4072999)
Affinity DataIC50: 3.82E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238218(CHEMBL4064413)
Affinity DataIC50: 4.77E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238235(CHEMBL4081915)
Affinity DataIC50: 5.93E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238224(CHEMBL4094081)
Affinity DataIC50: 5.99E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238215(CHEMBL4076930)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238228(CHEMBL4092048)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238211(CHEMBL4083306)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of AChE (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2019
Entry Details Article
PubMed